NASDAQ:MYOK
MyoKardia (MYOK)
Financials 
Technical Analysis https://www.businesswire.com/news/home/20201005005381/en/Bristol-Myers-Squibb-to-Acquire-MyoKardia-for-13.1-Billion-in-Cash Today, Bristol Myers announced it's buying MyoKardia (MYOK-Q) ifor US$13.1 billion cash. MyoKardia makes drugs to fight heart disease and heart conditions, including mavacamten, a drug for which they will file an application in Q1-2021. The stock has gotten really cheap. He loves this deal.
- «
- ‹
- 1
- ›
- »
MyoKardia (MYOK) Frequently Asked Questions
What is MyoKardia stock symbol?
MyoKardia is a American stock, trading under the symbol MYOK (previously MYOK-Q on Stockchase) on the NASDAQ (MYOK). It is usually referred to as NASDAQ:MYOK or MYOK
Is MyoKardia a buy or a sell?
In the last year, there was no coverage of MyoKardia published on Stockchase.
Is MyoKardia a good investment or a top pick?
MyoKardia was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for MyoKardia.
Why is MyoKardia stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
Is MyoKardia worth watching?
In the last year 0 stock analysts on Stockchase covered MyoKardia. The stock is worth watching.
What is MyoKardia stock price?
On 2020-11-16, MyoKardia (MYOK) stock closed at a price of $224.92.
